Vaccine confidence has never been more important, as the world waits for the first COVID-19 protection options to move t...
The role of a protein in detecting the common cold virus and kickstarting an immune response to fight infection has been...
When COVID-19 swept through the globe, it put immense pressure on healthcare systems around the world; leading to an abr...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...
Cell ID Pte. Ltd., a Singapore-incorporated med-tech company, is selling a palm-sized portable genetic test kit that use...
Singapore based DocDoc Pte Ltd., the world’s first patient intelligence company, has partnered with SpesNet Global...
COVID-19 pandemic has changed the way healthcare, pharma and clinical industry operate and has propelled the pace of dig...
Nearly a year since the world first learned of the novel coronavirus disease 2019, COVID-19, many questions remain about...
Zuellig Pharma, a leading healthcare services provider in Asia headquartered in Singapore, announced that it will signif...
The sixth edition of the ESMO Asia Congress, being held virtually due to COVID-19, opened today with over 2,500 medical ...
AUM Biosciences (AUM), a global, clinical-stage healthcare company based in Singapore, focused on discovering, acquiring...
OnRobot has opened registration for ‘OnRobot Expo’ – a global, interactive digital robotics event focu...
INEX Innovate's iGene Laboratory (iGene) has announced a project with Eli Lilly and Company's research un...
Gilead Sciences, Inc. on 16 Nov 2020 announced the recipients of its first Asia HIV Research Scholar Program. The P...
Clinical researchers from Singapore's National University Hospital (NUH) have found that a smartphone app-based lif...
Mednefits, an employee medical benefits platform, announced on 17 Nov 2020 the raise of SGD 8 million in its Series A fu...
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singa...
Singapore's Health Sciences Authority (HSA) recently approved an immunotherapy regimen (Tecentriq + Avastin) t...
